SCHEMBL722953

SCHEMBL722953

NC(=O)OCc1cccc(Cl)c1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.59
PNMT P11086 1/20 0.52
TAAR1 Q96RJ0 1/20 0.47
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP12 P39900 1/20 0.43
GRM2 Q14416 1/20 0.42
GRM3 Q14832 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
TSHR P16473 1/20 0.40
ERCC5 P28715 1/20 0.40
FEN1 P39748 1/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4607557 0.85 IDO1 (0.58) IDO1PNMTTAAR1MMP1MMP2
SCHEMBL2345808 0.85 IDO1 (0.58) IDO1PNMTTAAR1MMP1MMP2
SCHEMBL286760 0.85 IDO1 (0.57) IDO1PNMTMMP1MMP2MMP9
SCHEMBL7756741 0.84 IDO1 (0.56) IDO1PNMTTAAR1MMP1MMP2
SCHEMBL29272771 0.83 MMP1 (0.41) IDO1MMP1MMP2MMP9MMP12
SCHEMBL28803183 0.83 FFAR4 (0.43) IDO1MMP1MMP2MMP9MMP12
SCHEMBL4590126 0.83 TAAR1 (0.53) IDO1PNMTTAAR1TSHRERCC5
SCHEMBL13034147 0.82 IDO1 (0.55) IDO1PNMTTAAR1MMP1MMP2
SCHEMBL7083017 0.81 IDO1 (0.53) IDO1PNMTTAAR1MMP1MMP2
SCHEMBL7088966 0.81 IDO1 (0.53) IDO1PNMTTAAR1MMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3162438-A1 POLYMER SUPPORTED VICINAL DIAMINES AND THEIR USE AS CATALYST IN THE HAJOS-PARRISH-ENDER-SAUSER-WIECHERT AND ROBINSON ANNULATION REACTIONS Fundació Institut Català d'Investigació Química (ES) 2017-05-03 EP claimed
WO-2023168066-A9 OXIME-BASED HOT MELT ADHESIVES FOR REWORK, REPAIR AND RECYCLE CONAGEN INC. (US) 2024-06-20 WO disclosed
WO-2023168066-A1 OXIME-BASED HOT MELT ADHESIVES FOR REWORK, REPAIR AND RECYCLE CONAGEN INC. (US) 2023-09-07 WO disclosed
EP-3737362-A1 COMBINATION OF A SELECTIVE HISTONE DEACETYLASE 3 (HDAC3) INHIBITOR AND AN IMMUNOTHERAPY AGENT FOR THE TREATMENT OF CANCER KDAC THERAPEUTICS, INC. (US) 2020-11-18 EP disclosed
WO-2017190061-A1 SYNTHETIC DNA BINDING DOMAIN PEPTIDES AND USES THEREOF THE UNIVERSITY OF CHICAGO (US) 2017-11-02 WO disclosed
EP-3162438-A1 POLYMER SUPPORTED VICINAL DIAMINES AND THEIR USE AS CATALYST IN THE HAJOS-PARRISH-ENDER-SAUSER-WIECHERT AND ROBINSON ANNULATION REACTIONS Fundació Institut Català d'Investigació Química (ES) 2017-05-03 EP disclosed
WO-2012027555-A2 GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-03-01 WO disclosed
EP-2367798-A2 TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Cambria Pharmaceuticals, Inc. (US) 2011-09-28 EP disclosed
EP-2331018-A1 ESOPHAGEAL VALVE Vysera Biomedical Limited (IE) 2011-06-15 EP disclosed
EP-2303888-A2 METHODS AND COMPOUNDS FOR ANTIMICROBIAL INTERVENTION President and Fellows of Harvard College (US) 2011-04-06 EP disclosed
WO-2010059241-A2 TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS CAMBRIA PHARMACEUTICALS, INC. (US) 2010-05-27 WO disclosed
WO-2009153770-A1 ESOPHAGEAL VALVE VYSERA BIOMEDICAL LIMITED (IE) 2009-12-23 WO disclosed
WO-2009151561-A2 METHODS AND COMPOUNDS FOR ANTIMICROBIAL INTERVENTION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2009-12-17 WO disclosed